Communication between neoplastic cells and cells of their microenvironment is critical to cancer progression. To investigate the role of cytoneme-mediated signaling as a mechanism for distributing growth factor signaling proteins between tumor and tumor-associated cells, we analyzed EGFR and RET Drosophila tumor models. We tested several genetic loss-of-function conditions that impair cytoneme-mediated signaling. diaphanous, Neuroglian, SCAR, capricious are genes that cytonemes require during normal development. Genetic inhibition of cytonemes restored apical basal polarity to tumor cells, reduced tumor growth, and increased organism survival. These findings suggest that cytonemes traffic the signaling proteins that move between tumor and stromal cells, and that cytoneme-mediated signaling is required for tumor growth and malignancy.
and pro-angiogenic factors (e.g. VEGF). These proteins may function as either autocrine, juxtacrine, or paracrine signals, but it is not known how they move into or within the tumor microenvironment.
Studies of tumor models in Drosophila exploit the experimental attributes of the fly that provide uniquely powerful ways to investigate tumorigenesis (Sonoshita and Cagan, 2017) . We tested two models for the roles of cytonemes. Cytonemes are specialized, actin-based filopodia that extend between cells that produce and secrete signaling proteins and cells that receive them.
The signaling proteins move along cytonemes and exchange at transient synapses that form where cytonemes contact target cells. These synapses are similar to neuronal synapses in both constitution and properties Roy et al., 2014) , and are necessary for paracrine FGF, BMP/Dpp, Hedgehog, Wnt/Wingless (Wnt/Wg), and Notch signaling during normal development of Drosophila epithelial tissues (González-Méndez et al., 2017; Huang and Kornberg, 2016; Roy et al., 2014) .
EGFR activating mutations are drivers of several types of human cancers (Sibilia et al., 2007) .
Although elevated EGFR expression of wild type EGFR is not sufficient for tumorigenesis, additional genetic changes are necessary, such as over-expression of Perlecan, a heparan sulfate proteoglycan (HSPG) component of the ECM (Jiang and Couchman, 2003) . In Drosophila, ectopic over-expression of Perlecan and EGFR in epithelial cells of the wing imaginal disc drives tumorigenesis (Herranz et al., 2014) . Growth and metastasis of the epithelial cells requires crosstalk with closely associated mesenchymal myoblasts, which also proliferate abnormally when Perlecan and EGFR are over-expressed in epithelial neighbors. The crosstalk includes BMP/Dpp signaling in the epithelial cells and Wnt/Wg signaling in the mesenchymal cells (Herranz et al., 2014) .
The RET gene is the primary oncogenic driver for MEN2 (multiple endocrine neoplasia type 2) syndrome. MEN2 is characterized by several types of neoplastic transformations, including an aggressive thyroid cancer called medullary thyroid carcinoma (MTC) . Fly models that overexpress RET MEN2 phenocopy aspects of the aberrant signaling in MEN2-related tumors, such as activation of the SRC signal transduction pathway, which promotes migration and metastasis of tumorigenic cells. Screens for small molecule suppressors of the Drosophila RET MEN2 over-expression tumors identified compounds that are more effective than the drugs that are currently used for patients (Dar et al., 2012; Read et al., 2005) .
In the work presented here we examined the role of cytoneme-mediated signaling in the EGFRPcn and the RET MEN2 models. Genetic inhibition of cytonemes by downregulation of diaphanous, Neuroglian and SCAR, genes previously shown to be essential in cytoneme-mediated signaling, reduced tumor growth and Dpp signaling, and suppressed lethality by 60% in the EGFR-Pcn tumor and by 30% in the RET MEN2 tumor. These results suggest that cytoneme-mediated signaling is necessary for tumor growth and that interfering with cytoneme-meditaed tumorstromal cell signaling might be a therapy for tumor suppression.
RESULTS

Tumor cells and stromal cells extend cytonemes
Most of the wing imaginal disc is a columnar epithelium that generates both the adult fly wing and cuticle of the dorsal thorax. The disc also includes myoblasts that grow and spread over much of the dorsal basal surface of the columnar epithelium; these mesenchymal cells will generate the flight muscles of the adult. Tracheal branches also adjoin the basal surface of the columnar epithelium, and one branch, the transverse connective, sprouts a bud (the air sac primordium (ASP), Fig. 1A ) that grows during the third instar period dependent on Dpp and FGF signaling proteins that are produced by the wing disc . The myoblasts relay Wg and Notch signaling between the disc and ASP (Huang and Kornberg, 2015) . Cytonemes mediate and are essential for the Dpp, FGF, Wg, and Notch signaling during development (Kornberg, 2014) .
To investigate whether cytonemes are also essential in tumorigenesis, we tested a cancer model that requires tumor-stroma interactions in which neoplastic transformation is driven by interactions between the wing disc epithelial cells and myoblasts (Herranz et al., 2014) .
Overexpression of wild type EGFR and Perlecan (pcn, a secreted heparan sulfate proteoglycan)
in the columnar epithelium drives proliferation of the epithelial cells (which are genetically modified) as well as their genetically wild type myoblast neighbors. Tumorigenesis depends on All rights reserved. No reuse allowed without permission.
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To determine if the tracheal system was also affected by the tumor conditions, we induced the EGFR-Pcn tumor and labelled the tracheal cells with membrane tethered GFP (with LHG lexO-CD2:GFP, a tracheal-specific driver (Shiga et al., 1996) ). In the EGFR-Pcn tumor discs, the trachea were morphologically abnormal, and were more extensive and more branched than normal (Fig.   1G ,H), suggesting that signaling to the genetically unmodified tracheal cells was also affected in the tumor discs.
Dpp localizes to the tumor epithelial cell cytonemes
In normal development, Dpp produced by wing disc cells at the anterior/posterior compartment border is transported by cytonemes to target cells in both the wing disc and other tissues, and cytoneme deficits lead to developmental defects . In the EGFR-Pcn tumor model, Dpp signals from the mutant epithelial cells to drive myoblast expansion (Herranz et al., 2014) . Dpp expression is upregulated in the epithelial cells ( Fig. 2A,A' ) and pMAD, the phosphorylated form of the Dpp signal transducer MAD, is highly enriched in the myoblasts ( Fig 
FGF signaling between epithelial cells and myoblasts
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To investigate the role of Bnl/FGF signaling in EGFR-Pcn tumorigenesis, we overexpressed a dominant negative FGFR mutant in the tumor cells to block FGF signaling (UAS-Btl DN ). We compared disc morphology, Dpp signaling (monitored by anti-pMad antibody staining), and myoblast distribution (monitored by anti-Cut antibody staining, a specific mark of myoblasts (Blochlinger et al., 1993) ) in control discs, EGFR-Pcn tumor discs, and EGFR-Pcn discs expressing Btl DN . Tumor discs were misshapen and six times larger than wild type discs, the number of Cutexpressing cells increased by four times, and anti-pMad staining was as well widespread and unpatterned (Fig. 3A,B,I ). Expression of Btl DN restored these features to normal. In discs overexpressing EGFR, Pcn, and Btl DN , morphology, the pattern of Dpp signaling, and distribution of myoblasts were indistinguishable from controls (Fig. 3C ). These results indicate that inhibition of FGF signaling in the tumor cells suppressed both tumor growth and myoblast proliferation, and restored Dpp signal transduction to normal; they suggest that ectopic Btl/FGFR expression and Bnl/FGF signaling are key drivers of the tumor.
Genetic suppression of tumor phenotypes
To assess the role of cytonemes in tumorigenesis, we examined discs in which cytonemes are impaired. Downregulation of diaphanous (dia), Neuroglian (Nrg), SCAR or Capricious (Caps)
reduces the number and length of cytonemes, and reduces signaling in tracheal cells, myoblasts and wing disc cells (Bischoff et al., 2013; Huang and Kornberg, 2015; Roy et al., 2014) . We expressed RNAi constructs to lower Dia, Nrg, SCAR and Caps levels in tumor cells, using
The 17, 2018; conditions that represent partial loss-of-function and do not perturb cell polarity, cell viability, or cell cycle during normal development (Chen et al., 2017; Kornberg, 2015, 2016 et al., 2014) . We monitored wing discs for morphology, Cut expression, and pMAD. In contrast to discs with EGFR-Pcn tumors, discs with tumor cells that expressed diaRNAi in addition to EGFR and Pcn were morphologically less distorted, only 1.2 times larger than wild type, and the number and distribution of Cut-expressing cells was close to normal (Fig 3D,I ). We also analyzed the apical-basal organization of the disc cells by motoring the distribution of Discs large (Dlg), which associates with the septate junction and localizes specifically to the apical compartment of the columnar epithelial cells. Sagittal optical sections of discs stained with antiDlg antibody reveal the specific apical distribution of Dlg characteristic of wild type cells is disorganized in EGFR-Pcn tumor discs (Fig. 3E,E' ). Expression of diaRNAi in the tumor cells restored the Dlg distribution to normal (Fig. 3E") .
The presence of cytonemes in both the tumor (columnar epithelial) and mesenchymal (myoblast) cells, and the essential role of the myoblasts for tumor progression raises the possibility that myoblast cytonemes might also play an essential role in tumorigenesis. To investigate the role of myoblast cytonemes, we expressed diaRNAi (with 1151-lexA lexOdiaRNAi) in the myoblasts of discs that overexpress EGFR and Pcn in the columnar epithelial cells. The morphology, Dpp signaling pattern and myoblast growth characteristic of the EGFRPcn tumors were suppressed (Fig. 3F,F',I ). This result is consistent with the idea that the myoblasts signal to the epithelial tumor cells and that this signaling is mediated by cytonemes. 
(B,B') EGFR-Pcn tumor, genotype: ap-Gal4,UAS-psqRNAi/+;UAS-EGFR,tub-Gal80 ts /UAS-CD8:GFP. (C,C') EGFR-Pcn +Btl DN expressed in epithelial cells. Genotype: ap-Gal4,UAS-psqRNAi/+;UAS-EGFR,tub-Gal80 ts /UAS-Btl DN . (D,D') EGFR-Pcn + diaRNAi in epithelial cells. Genotype: ap-Gal4,UAS-psqRNAi/+;UAS-EGFR,tub-Gal80 ts /UAS-diaRNAi. (E-E")
green). (H) Control adult wing. (H') EGFR-Pcn + diaRNAi wing, genotype: ap-Gal4,UAS-psqRNAi/UAS-CD8:GFP;UAS-EGFR,tub-Gal80 ts /UAS-diaRNAi. (I)
Quantification of the total wing disc area (blue) and relative area of Cut-expressing cells (orange) of control, EGFR+Pcn tumor, tumor + diaRNAi expressed in epithelial cells, diaRNAi expressed in myoblasts, NrgRNAi, SCARRNAi, Caps DN , NrgRNAi+diaRNAi, dsRNAi, ftRNAi and fjRNAi larvae. Data was normalized to control. Student's t test P values (P<0.05 to P >0.0005 for all except no significant difference for tumor + dsRNAi, ftRNAi and fjRNAi); n = 3-5 discs for each genotype. (J) Survival of EGFR-Pcn tumor, tumor + diaRNAi, NrgRNAi, SCARRNAi and Caps DN larvae to pupal (blue), pharate adult (orange) and adult stage (gray). Student's t test P values: (between P<0.05 and P >1.10 -8 ) with n = 15-30 larvae for each genotype.
The copyright holder for this preprint . http://dx.doi.org/10.1101/446542 doi: bioRxiv preprint first posted online Oct. 17, 2018;  Although EGFR and Pcn expression in the EGFR-Pcn model (driven by ap-Gal4) is restricted to the dorsal compartment of the wing disc, the tumors grow extensively and metastasize (Fig.   3G ,G"), and with no maturation beyond the larval stage (Herranz et al., 2014) . The tumorous condition is 100% lethal. However, the conditions of diaRNAi expression that reduce cytonemes and cytoneme-mediated signaling suppressed lethality: all the EGFR-Pcn tumor-bearing larvae pupated, approximately 75% reached the pharate adult stage, and approximately 60% survived to adult stage (Fig. 3J) . These surviving adults were fertile, and wing blade morphological defects were the only visible phenotype (Fig. 3H,H') . These results are consistent with the idea that cytoneme-mediated signaling is necessary for tumor growth and that interfering with tumorstromal cell signaling suppresses many if not all aspects of tumorigenesis.
Expression of NrgRNAi, SCARRNAi, CAPS DN in the epithelial cells of the EGFR-Pcn model reduced tumor growth, pMAD expression and number of Cut-expressing cells (Fig. 3I, Fig. 4A-D) .
Although these conditions improved survival, they were less effective than Btl DN (Fig. 2) or 
UAS-EGFR,tub-Gal80 ts /UAS-fjRNAi
The copyright holder for this preprint . http://dx.doi.org/10.1101/446542 doi: bioRxiv preprint first posted online Oct. 17, 2018;  diaRNAi (Figs. 3, 4) . To test whether the ameliorative effects of RNAi constructs might be additive, we expressed NrgRNAi and diaRNAi simultaneously in EGFR-Pcn tumor cells. Expression of both NrgRNAi and diaRNAi decreased tumor growth (Fig. 3I) , but compared to wild type wing discs, the discs were smaller and morphologically abnormal (Fig. 3I and 4) , and no pupae developed to adult stage. We surmise that these effects might be due to the combined effects of insufficient function of the Nrg and dia genes. We also tested the roles of three genes that are essential for planar cell polarity (Sharma and McNeill, 2013) : the dachsous (ds) and fat (ft) genes that encode cadherin family proteins, and four-jointed (fj) that encodes a transmembrane kinase. Expression of dsRNAi, ftRNAi or fjRNAi does not perturb cytoneme-mediated signaling (Huang and Kornberg, 2016) , and expression of these RNAi lines in the tumor cells had no apparent effect on tumorigenesis (Fig. 4E-G) .
Cytonemes in a RET-MEN2 tumor model
We investigated the role of cytonemes in the Drosophila RET-MEN2 tumor model developed by the Cagan lab (Dar et al., 2012) . This model mimics the mis-regulation of signaling pathways that have been implicated in MEN2-related tumors. Overexpression of RET MEN2 in a discrete set of wing disc epithelial cells (with ptc-Gal4) resulted in >4X increase in the number of ptc-expressing cells and a 9X increase in the portion of the disc that consists of ptc-expressing cells ( Figure 5A -C) (Dar et al., 2012) . Approximately one-half of the animals survive to the pupal stage, but none survived to adult. We tested whether diaRNAi expression in the RET-mutant cells affects tumor growth and survival, and observed that excessive growth of the ptc-expressing cells was suppressed by more than 4X (Fig. 5C,D) . Approximately two-thirds of the animals developed to the pupal stage, and one-third survived to adult. These flies were wild type in appearance, without any apparent visible abnormalities. These results are consistent with a general role for cytonemes in tumorigenesis and tumor progression.
DISCUSSION
The tumor microenvironment is a niche that responds to signaling proteins produced by tumor cells and supplies growth factors that support tumor growth and metastasis (Quail and Joyce, 2013) . Much ongoing work seeks inhibitors of tumorigenesis that target the signaling molecules All rights reserved. No reuse allowed without permission.
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Our previous work established that during Drosophila development, paracrine signaling by the signaling proteins/growth factors Dpp, FGF, Wg, Notch, Hedgehog, and Notch is mediated by cytonemes. Cytonemes are specialized filopodia that extend between signal producing and (C) Quantification of the area of the disc expressing GFP (% of disc) in control, RET tumor and RET + diaRNAi discs. Significance was analyzed using Student's t-test (P<1.10 -5 ) and a total n of 4 discs. (D) Unfixed RET + diaRNAi wing disc expressing CD8:GFP (green). Genotype: ptc-Gal4,CD8:GFP;UAS-RET MEN2 /UASdiaRNAi. (E) Survival of RET-tumor and RET+ diaRNAi larvae to pupae (blue) and adults (orange). Significance using Student's t-test (P<0.05 for RET+ diaRNAi pupae and P<0.005 for RET+ diaRNAi adults) with n = 30-40 larvae for each genotype.
The copyright holder for this preprint . http://dx.doi.org/10.1101/446542 doi: bioRxiv preprint first posted online Oct. 17, 2018;  signal receiving cells, making synaptic contacts where the signaling proteins transfer from producing to receiving cells. To extend this work to tumorigenesis, we applied the strategies and tools we developed for our previous studies to ask if cytonemes are present in the tumor microenvironment, and if genetic conditions that inhibit cytoneme function and cytonemedependent signaling in normal development also inhibit tumorigenesis.
In a EFGR-Pcn tumor model, we found that cytonemes extend from both Drosophila tumor and stromal cells (Figs. 1 and 2 ). This is consistent with previous studies that reported increased signaling between tumor and stromal cells in this model (Herranz et al., 2014) , and with the presence of cytonemes in many other contexts of paracrine signaling (Bischoff et al., 2013; Chen et al., 2017; Eom et al., 2015; Inaba et al., 2015; Roy et al., 2014; Sanders et al., 2013; Stanganello et al., 2015) . We confirmed that Dpp is expressed by the tumor cells ( Fig. 2 ; (Herranz et al., 2014) ), and found that ectopic FGF signaling also has an essential role in this tumor (Figs. 2 and 3) . The implied functional connections between the EGF, Dpp, and FGF signaling pathways have not been identified.
We also found conditions that impair cytonemes and cure flies of lethal tumors in both EGFRPcn and RET models. We selected four genes from among the more than twenty that are known to be essential for cytoneme-mediated signaling (Bischoff et al., 2013; Huang and Kornberg, 2016; Roy et al., 2014) . dia, Nrg, SCAR, and Caps are recessive lethal genes whose functions can be partially reduced in genetic mosaics without affecting viability, cell shape, or the cell cycle, but are necessary for cytoneme function. Downregulating any one of these genes improved viability in the EGFR-Pcn model; dia inhibition was most effective in both models, and the cures that they effected suggest that cytoneme-mediated signaling, which might be a general mechanism for tumorigenesis in a variety of cancers, might also be a potential target for therapy.
The high degree of evolutionary conservation with human proteins make Drosophila a clinically relevant platform for understanding mechanisms human disease, and Drosophila tumor models have successfully identified new therapeutic candidates for colorectal, lung and thyroid and stem-cells derived cancers (Bangi et al., 2016; Levine and Cagan, 2016; Markstein et al., 2014) .
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The copyright holder for this preprint . http://dx.doi.org/10.1101/446542 doi: bioRxiv preprint first posted online Oct. 17, 2018;  gRNA sequence: CGCTCCATTCGGGACGTGTCTGG The gRNA sequence without the PAM was cloned into pCFD-3 vector obtained from Addgene.
Dpp:Cherry CISPR lines pCFD-3 gRNA vector and Dpp:mCherry donor vector were co-injected into Cas9 expressing flies (nanos-Cas9) by Rainbow Transgenics. The resulting CRISPR-generated flies were screened and verified by sequencing. The Dpp:mCherry fly is viable and homozygous and hemizygous normal.
EGFR-Pcn tumor EGFR-Pcn tumors were induced as described by Herranz et al, (Herranz et al., 2014) by overexpression of EGFR and down-regulation of pipsqueak (psq), which leads to increased levels of Pcn. Female flies from the stock ap-Gal4,UAS-psqRNAi/CyO;UAS-EGFR,tub-Gal80 ts were crossed to males of the corresponding genotypes at 18°C, and were cultured at 18°C to maintain Gal80 repression of Gal4 and allow normal development. After 5 days larvae were transferred to 29°C
to induce Gal4 expression and tumor growth. Tumor growth was induced for 7 days, unless otherwise indicated, whereupon larvae were dissected for live imaging or immunostaining, or were maintained at 29°C for survival studies. To control for possible effects on Gal4 expression, all tested genotypes had three UAS transgenes -either UAS-EGFR, UAS-psqRNAi and UAS-CD8:GFP for tumor flies, or UAS-EGFR, UAS-psqRNAi and additional RNAi for comparisons.
RET tumor model
Female flies from the RET MEN2 stock (Dar et al., 2012) were crossed at room temperature to either ptc-Gal4, 2xUAS-CD8:GFP males or ptc-Gal4, UAS-CD8:GFP, UAS-diaRNAi males. For analysis of discs, embryos from one day collections were transferred to 29°C and cultured to third instar stage. For survival comparisons, animals were cultured at 25°C.
Live imaging of wing imaginal discs
Wing discs with trachea attached were dissected in cold phosphate-buffered saline (PBS), placed on a coverslip and mounted upside-down on a coverslip on a depression slide as described (Huang and Kornberg, 2015) . Samples were imaged with a Leica TCS SPE confocal or an Olympus FV3000 inverted confocal laser scanning microscope.
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